Skip to content

Advertisement

BMC Health Services Research

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France

  • Marius Huguet1Email authorView ORCID ID profile,
  • Lionel Perrier2,
  • Olivia Bally3,
  • David Benayoun4,
  • Pierre De Saint Hilaire4,
  • Dominique Beal Ardisson5,
  • Magali Morelle2,
  • Nathalie Havet6,
  • Xavier Joutard7,
  • Pierre Meeus3,
  • Philippe Gabelle8,
  • Jocelyne Provençal9,
  • Céline Chauleur10,
  • Olivier Glehen4,
  • Amandine Charreton3,
  • Fadila Farsi11 and
  • Isabelle Ray-Coquard12
BMC Health Services ResearchBMC series – open, inclusive and trusted201818:3

https://doi.org/10.1186/s12913-017-2802-2

Received: 24 May 2017

Accepted: 14 December 2017

Published: 4 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
24 May 2017 Submitted Original manuscript
14 Jul 2017 Reviewed Reviewer Report - Marko Simunovic
9 Sep 2017 Reviewed Reviewer Report - Stephanie V Blank
24 Oct 2017 Author responded Author comments - Marius Huguet
Resubmission - Version 2
24 Oct 2017 Submitted Manuscript version 2
6 Nov 2017 Reviewed Reviewer Report - Marko Simunovic
21 Nov 2017 Author responded Author comments - Marius Huguet
Resubmission - Version 3
21 Nov 2017 Submitted Manuscript version 3
6 Dec 2017 Author responded Author comments - Marius Huguet
Resubmission - Version 4
6 Dec 2017 Submitted Manuscript version 4
Publishing
14 Dec 2017 Editorially accepted
4 Jan 2018 Article published 10.1186/s12913-017-2802-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Univ Lyon, University Lumière Lyon 2, GATE L-SE UMR 5824, Ecully, France
(2)
Univ Lyon, Léon Bérard Cancer Center, GATE L-SE UMR 5824, Lyon, France
(3)
Leon Berard Cancer Centre, Lyon, France
(4)
University Hospital of Lyon, Lyon, France
(5)
Private Hospital Jean Mermoz, Lyon, France
(6)
Univ Lyon, University Claude Bernard Lyon 1, ISFA, Laboratoire SAF, Lyon, France
(7)
Lest-UMR 7317, Aix-Marseille University, Marseille, France
(8)
Groupe Hospitalier Mutualiste, Grenoble, France
(9)
Hospital Métropole de Savoie, Chambery, France
(10)
University Hospital, Saint-Priest-en-Jarez, France
(11)
Réseau Espace Santé Cancer Rhône-Alpes, Lyon, France
(12)
Univ Lyon, Léon Bérard Cancer Center, EA 7425 HESPER, Lyon, France

Advertisement